Skip to main content
Powered by ShareScore

Find research datasets worth reusing

Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.

255

datasets available to search

ShareScore release 0.9.0

Reset

Dataset results

255 results for “Mast cells”

Learn how ShareScore rates datasets ↗
ClinicalTrials.gov40/100

Efficacy and Safety of Midostaurin in Patients With Aggressive Systemic Mastocytosis or Mast Cell Leukemia

ClinicalTrials.gov study NCT00782067. IPD Sharing: UNDECIDED. Countries: 12. Publications: 3.

restrictedIPD-UNDECIDEDFeb 2026View details →
dryad36/100

Landscape of Mast cell populations across organs in mice and humans

<p><span>Mast cells (MCs) are tissue-resident immune cells which exhibit homeostatic and neuron-associated functions. Here we combined whole-tissue imaging and single-cell RNA sequencing datasets to generate a pan-organ analysis of MCs in mice and humans at steady state. In mice, we identify two mutually exclusive MC populations, MrgprB2<sup>+</sup> connective tissue-type MCs and MrgprB2<sup>neg</sup> mucosal-type MCs, with specific transcriptomic core signatures. While MrgprB2<sup>+</sup> MCs develop<em> in-utero</em> independently of the bone marrow, MrgprB2<sup>neg</sup> MCs develop after birth and are renewed by bone marrow progenitors. In humans, we unbiasedly identify 7 MC subsets (MC1 to 7) distributed across 12 organs with different transcriptomic core signatures. MC1 are preferentially enriched in the bladder, MC2 in the lungs, and MC4, MC6 and MC7 in the skin. Conversely, MC3 and MC5 are shared by most organs, but not skin. This comprehensive analysis offers valuable insights into the natural diversity of MC subtypes in both mice and humans.</span></p>

opencc-zeroJun 2023View details →
ClinicalTrials.gov36/100

Phase 2 Midostaurin in Aggressive Systemic Mastocytosis and Mast Cell Leukemia

ClinicalTrials.gov study NCT00233454. IPD Sharing: NO. Countries: 1. Publications: 3.

closedIPD-NOFeb 2026View details →
ClinicalTrials.gov36/100

Mast Cell Activation Test in Allergic Disease

ClinicalTrials.gov study NCT03406325. IPD Sharing: NO. Countries: 1. Publications: 1.

closedIPD-NOFeb 2026View details →
ClinicalTrials.gov36/100

Brentuximab Vedotin in Treating Patients With Advanced Systemic Mastocytosis or Mast Cell Leukemia

ClinicalTrials.gov study NCT01807598. IPD Sharing: NO. Countries: 1. Publications: 1.

closedIPD-NOFeb 2026View details →
dryad36/100

Data from: Analyses Xenopus laevis mast cells, neutrophils, and mast cell-enriched, chytrid infected skin

Open the record for dataset details and reuse information.

publicJul 2024View details →
dryad36/100

Landscape of Mast cell populations across organs in mice and humans

Open the record for dataset details and reuse information.

publicJun 2023View details →
ClinicalTrials.gov32/100

Study of Mast Cell Precursors

ClinicalTrials.gov study NCT00001756. IPD Sharing: Not stated. Countries: 1. Publications: 5.

restrictedIPD-UNDECIDEDFeb 2026View details →
ClinicalTrials.gov32/100

MAST - Magnesium for Sickle Cell Acute Crisis in Children

ClinicalTrials.gov study NCT00313963. IPD Sharing: Not stated. Countries: 1. Publications: 1.

restrictedIPD-UNDECIDEDFeb 2026View details →
ClinicalTrials.gov32/100

Clonal Mast Cell Disorders in Exercise-Induced Anaphylaxis

ClinicalTrials.gov study NCT01326741. IPD Sharing: Not stated. Countries: 1. Publications: 1.

restrictedIPD-UNDECIDEDFeb 2026View details →
ClinicalTrials.gov32/100

Mast Cells in Male Pelvic Pain and and Lower Urinary Tract Dysfunction

ClinicalTrials.gov study NCT03167216. IPD Sharing: NO. Countries: 1. Publications: 3.

closedIPD-NOFeb 2026View details →
ClinicalTrials.gov32/100

Intestinal Microbiota Transplant Prior to Allogeneic Stem Cell Transplant (MAST) Trial

ClinicalTrials.gov study NCT06355583. IPD Sharing: YES. Countries: 1. Publications: 29.

controlledIPD-YESFeb 2026View details →
ClinicalTrials.gov32/100

Study of Factors Regulating Mast Cell Proliferation

ClinicalTrials.gov study NCT00044122. IPD Sharing: NO. Countries: 1. Publications: 5.

closedIPD-NOFeb 2026View details →
ClinicalTrials.gov32/100

Masitinib for the Treatment of Severe Mast Cell Activation Syndrome

ClinicalTrials.gov study NCT05449444. IPD Sharing: NO. Countries: 2. Publications: 2.

closedIPD-NOFeb 2026View details →
zenodo28/100

Crosstalk between Mast Cells and Lung Fibroblasts Is Modified by Alveolar Extracellular Matrix and Influences Epithelial Migration

<p>Datasets for&nbsp;the data generated and presented&nbsp;in&nbsp;the article:&nbsp;https://doi.org/10.3390/ijms22020506</p>

opencc-by-4.0Jan 2021View details →
dryad28/100

Data from: A synonymous germline variant in a gene encoding a cell adhesion molecule is associated with cutaneous mast cell tumour development in Labrador and Golden Retrievers

Mast cell tumours are the most common type of skin cancer in dogs, representing a significant concern in canine health. The molecular pathogenesis is largely unknown, but breed-predisposition for mast cell tumour development suggests the involvement of inherited genetic risk factors in some breeds. In this study, we aimed to identify germline risk factors associated with the development of mast cell tumours in Labrador Retrievers, a breed with an elevated risk of mast cell tumour development. Using a methodological approach that combined a genome-wide association study, targeted next generation sequencing, and TaqMan genotyping, we identified a synonymous variant in the DSCAM gene on canine chromosome 31 that is associated with mast cell tumours in Labrador Retrievers. DSCAM encodes a cell-adhesion molecule. We showed that the variant has no effect on the DSCAM mRNA level but is associated with a significant reduction in the level of the DSCAM protein, suggesting that the variant affects the dynamics of DSCAM mRNA translation. Furthermore, we showed that the variant is also associated with mast cell tumours in Golden Retrievers, a breed that is closely related to Labrador Retrievers and that also has a predilection for mast cell tumour development. The variant is common in both Labradors and Golden Retrievers and consequently is likely to be a significant genetic contributor to the increased susceptibility of both breeds to develop mast cell tumours. The results presented here not only represent an important contribution to the understanding of mast cell tumour development in dogs, as they highlight the role of cell adhesion in mast cell tumour tumourigenesis, but they also emphasise the potential importance of the effects of synonymous variants in complex diseases such as cancer.

opencc-zeroDec 2018View details →
ClinicalTrials.gov28/100

7 Day Study of Mast Cell Inhibitor, R926112, in Patients With Symptomatic Seasonal Allergic Rhinitis

ClinicalTrials.gov study NCT00115089. IPD Sharing: Not stated. Countries: 0. Publications: 1.

restrictedIPD-UNDECIDEDFeb 2026View details →
ClinicalTrials.gov28/100

A Prospective Clinical Trial Comparing Serum Mast Cell Tryptase (SMCT) Levels to Arthrofibrosis Rates Among Primary Total Knee Arthroplasty (TKA) Patients

ClinicalTrials.gov study NCT03598829. IPD Sharing: NO. Countries: 1. Publications: 0.

closedIPD-NOFeb 2026View details →
ClinicalTrials.gov28/100

A Cohort Study of Correlation Between Mast Cells and Prognosis in Patients With Acute Myocardial Infarction

ClinicalTrials.gov study NCT05802667. IPD Sharing: NO. Countries: 0. Publications: 1.

closedIPD-NOFeb 2026View details →
ClinicalTrials.gov28/100

Characteristics of Mast Cells in Mastocytosis

ClinicalTrials.gov study NCT00001356. IPD Sharing: Not stated. Countries: 1. Publications: 3.

restrictedIPD-UNDECIDEDFeb 2026View details →

ScienceDex guides

Understand access before you commit

These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.

Compare curated datasets

Allen Brain Atlas

Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.

allen-brain-atlas
neuroscienceopenDocumentation, web resources, and API references are available online.
Last verified 2026-04-30Open record

Annotated Behaviour and Observability Dataset (ABODe)

ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.

abode-home-cage
behavioral-neuroscienceopenThe DataShare record exposes download links for annotations, documentation, license text, and the zipped per-snippet data directory.
Last verified 2026-04-30Open record

DANDI Archive for NWB datasets

DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.

dandi-nwb
electrophysiologyopenPublished Dandiset metadata and archive endpoints are available through the production DANDI API.
Last verified 2026-04-30Open record

International Brain Laboratory public data

The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.

ibl
behavioral-neuroscienceopenPublic sessions can be searched and loaded from the IBL public data server through ONE.
Last verified 2026-04-29Open record

OpenNeuro

OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.

openneuro
neuroscienceopenPublished datasets are available on demand over the internet.
Last verified 2026-04-29Open record